(AMBA) Ambarella - Overview
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: KYG037AX1015
Stock: Chips, Processors, Software, Cameras
Total Rating 22
Risk 23
Buy Signal -1.04
| Risk 5d forecast | |
|---|---|
| Volatility | 70.4% |
| Relative Tail Risk | -12.1% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.24 |
| Alpha | -43.84 |
| Character TTM | |
|---|---|
| Beta | 2.626 |
| Beta Downside | 3.431 |
| Drawdowns 3y | |
|---|---|
| Max DD | 54.85% |
| CAGR/Max DD | -0.22 |
EPS (Earnings per Share)
Revenue
Description: AMBA Ambarella March 04, 2026
Ambarella, Inc. develops semiconductor solutions for artificial intelligence (AI) processing, advanced image signal processing, and high-definition compression.
The companys system-on-a-chip (SoC) designs integrate video and image processing, AI algorithms, and audio processing. This integration is common in the semiconductor industry to optimize performance and power efficiency.
Ambarellas products are used across various sectors, including automotive (e.g., ADAS cameras, autonomous vehicle controllers), IoT (e.g., security cameras), and industrial applications (e.g., robotics). The company also serves consumer markets with solutions for wearable and action cameras. Its business model involves selling solutions to original design manufacturers (ODMs) and original equipment manufacturers (OEMs).
For more detailed financial and operational insights, consider exploring ValueRay.
Headlines to watch out for
- Automotive sector demand for AI chips drives revenue growth
- IoT security camera market expansion boosts chip sales
- Research and development spending impacts profitability
- Global semiconductor supply chain disruptions affect production
- Competition from larger chipmakers pressures market share
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income: -75.9m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.09 > 0.02 and ΔFCF/TA 10.04 > 1.0 |
| NWC/Revenue: 59.47% < 20% (prev 70.05%; Δ -10.59% < -1%) |
| CFO/TA 0.10 > 3% & CFO 80.1m > Net Income -75.9m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 2.31 > 1.5 & < 3 |
| Outstanding Shares: last quarter (43.2m) vs 12m ago 3.24% < -2% |
| Gross Margin: 59.19% > 18% (prev 0.60%; Δ 5859 % > 0.5%) |
| Asset Turnover: 52.53% > 50% (prev 41.35%; Δ 11.18% > 0%) |
| Interest Coverage Ratio: -2.57 > 6 (EBITDA TTM -69.1m / Interest Expense TTM 20.7m) |
Altman Z'' -1.60
| A: 0.29 (Total Current Assets 410.3m - Total Current Liabilities 177.9m) / Total Assets 798.6m |
| B: -0.41 (Retained Earnings -327.9m / Total Assets 798.6m) |
| C: -0.07 (EBIT TTM -53.0m / Avg Total Assets 743.8m) |
| D: -1.61 (Book Value of Equity -327.3m / Total Liabilities 203.8m) |
| Altman-Z'' Score: -1.60 = D |
Beneish M -3.04
| DSRI: 0.96 (Receivables 39.2m/29.8m, Revenue 390.7m/284.9m) |
| GMI: 1.02 (GM 59.19% / 60.50%) |
| AQI: 0.89 (AQ_t 0.46 / AQ_t-1 0.51) |
| SGI: 1.37 (Revenue 390.7m / 284.9m) |
| TATA: -0.20 (NI -75.9m - CFO 80.1m) / TA 798.6m) |
| Beneish M-Score: -3.04 (Cap -4..+1) = AA |
What is the price of AMBA shares?
As of March 09, 2026, the stock is trading at USD 52.38 with a total of 958,076 shares traded.
Over the past week, the price has changed by -14.20%, over one month by -19.73%, over three months by -31.71% and over the past year by +7.02%.
Over the past week, the price has changed by -14.20%, over one month by -19.73%, over three months by -31.71% and over the past year by +7.02%.
Is AMBA a buy, sell or hold?
Ambarella has received a consensus analysts rating of 3.87.
Therefore, it is recommended to buy AMBA.
- StrongBuy: 5
- Buy: 3
- Hold: 7
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the AMBA price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 89.6 | 71% |
| Analysts Target Price | 89.6 | 71% |
AMBA Fundamental Data Overview March 09, 2026
P/E Forward = 69.9301
P/S = 5.7711
P/B = 3.7909
P/EG = 2.2782
Revenue TTM = 390.7m USD
EBIT TTM = -53.0m USD
EBITDA TTM = -69.1m USD
Long Term Debt = 11.4m USD (estimated: total debt 13.4m - short term 2.03m)
Short Term Debt = 2.03m USD (from shortTermDebt, last quarter)
Debt = 13.4m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -177.6m USD (from netDebt column, last quarter)
Enterprise Value = 1.96b USD (2.25b + Debt 13.4m - CCE 312.6m)
Interest Coverage Ratio = -2.57 (Ebit TTM -53.0m / Interest Expense TTM 20.7m)
EV/FCF = 25.78x (Enterprise Value 1.96b / FCF TTM 75.9m)
FCF Yield = 3.88% (FCF TTM 75.9m / Enterprise Value 1.96b)
FCF Margin = 19.42% (FCF TTM 75.9m / Revenue TTM 390.7m)
Net Margin = -19.42% (Net Income TTM -75.9m / Revenue TTM 390.7m)
Gross Margin = 59.19% ((Revenue TTM 390.7m - Cost of Revenue TTM 159.4m) / Revenue TTM)
Gross Margin QoQ = 57.66% (prev 60.25%)
Tobins Q-Ratio = 2.45 (Enterprise Value 1.96b / Total Assets 798.6m)
Interest Expense / Debt = 9.57% (Interest Expense 1.29m / Debt 13.4m)
Taxrate = 21.0% (US default 21%)
NOPAT = -41.9m (EBIT -53.0m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 2.31 (Total Current Assets 410.3m / Total Current Liabilities 177.9m)
Debt / Equity = 0.02 (Debt 13.4m / totalStockholderEquity, last quarter 594.8m)
Debt / EBITDA = 2.57 (negative EBITDA) (Net Debt -177.6m / EBITDA -69.1m)
Debt / FCF = -2.34 (Net Debt -177.6m / FCF TTM 75.9m)
Total Stockholder Equity = 583.5m (last 4 quarters mean from totalStockholderEquity)
RoA = -10.20% (Net Income -75.9m / Total Assets 798.6m)
RoE = -13.00% (Net Income TTM -75.9m / Total Stockholder Equity 583.5m)
RoCE = -8.91% (EBIT -53.0m / Capital Employed (Equity 583.5m + L.T.Debt 11.4m))
RoIC = -7.23% (negative operating profit) (NOPAT -41.9m / Invested Capital 579.8m)
WACC = 15.54% (E(2.25b)/V(2.27b) * Re(15.59%) + D(13.4m)/V(2.27b) * Rd(9.57%) * (1-Tc(0.21)))
Discount Rate = 15.59% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 2.03%
[DCF] Terminal Value 44.35% ; FCFF base≈75.9m ; Y1≈49.8m ; Y5≈22.7m
[DCF] Fair Price = 8.83 (EV 202.5m - Net Debt -177.6m = Equity 380.1m / Shares 43.1m; r=15.54% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: -15.40 | EPS CAGR: -27.76% | SUE: 0.94 | # QB: 14
Revenue Correlation: 32.37 | Revenue CAGR: 2.99% | SUE: 0.47 | # QB: 0
EPS next Quarter (2026-04-30): EPS=0.10 | Chg7d=+0.037 | Chg30d=+0.037 | Revisions Net=+4 | Analysts=12
EPS current Year (2027-01-31): EPS=0.75 | Chg7d=+0.133 | Chg30d=+0.133 | Revisions Net=+7 | Growth EPS=+21.1% | Growth Revenue=+12.8%
EPS next Year (2028-01-31): EPS=1.09 | Chg7d=+0.225 | Chg30d=+0.225 | Revisions Net=+1 | Growth EPS=+44.6% | Growth Revenue=+13.7%
[Analyst] Revisions Ratio: +0.67 (5 Up / 1 Down within 30d for Next Quarter)
P/S = 5.7711
P/B = 3.7909
P/EG = 2.2782
Revenue TTM = 390.7m USD
EBIT TTM = -53.0m USD
EBITDA TTM = -69.1m USD
Long Term Debt = 11.4m USD (estimated: total debt 13.4m - short term 2.03m)
Short Term Debt = 2.03m USD (from shortTermDebt, last quarter)
Debt = 13.4m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -177.6m USD (from netDebt column, last quarter)
Enterprise Value = 1.96b USD (2.25b + Debt 13.4m - CCE 312.6m)
Interest Coverage Ratio = -2.57 (Ebit TTM -53.0m / Interest Expense TTM 20.7m)
EV/FCF = 25.78x (Enterprise Value 1.96b / FCF TTM 75.9m)
FCF Yield = 3.88% (FCF TTM 75.9m / Enterprise Value 1.96b)
FCF Margin = 19.42% (FCF TTM 75.9m / Revenue TTM 390.7m)
Net Margin = -19.42% (Net Income TTM -75.9m / Revenue TTM 390.7m)
Gross Margin = 59.19% ((Revenue TTM 390.7m - Cost of Revenue TTM 159.4m) / Revenue TTM)
Gross Margin QoQ = 57.66% (prev 60.25%)
Tobins Q-Ratio = 2.45 (Enterprise Value 1.96b / Total Assets 798.6m)
Interest Expense / Debt = 9.57% (Interest Expense 1.29m / Debt 13.4m)
Taxrate = 21.0% (US default 21%)
NOPAT = -41.9m (EBIT -53.0m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 2.31 (Total Current Assets 410.3m / Total Current Liabilities 177.9m)
Debt / Equity = 0.02 (Debt 13.4m / totalStockholderEquity, last quarter 594.8m)
Debt / EBITDA = 2.57 (negative EBITDA) (Net Debt -177.6m / EBITDA -69.1m)
Debt / FCF = -2.34 (Net Debt -177.6m / FCF TTM 75.9m)
Total Stockholder Equity = 583.5m (last 4 quarters mean from totalStockholderEquity)
RoA = -10.20% (Net Income -75.9m / Total Assets 798.6m)
RoE = -13.00% (Net Income TTM -75.9m / Total Stockholder Equity 583.5m)
RoCE = -8.91% (EBIT -53.0m / Capital Employed (Equity 583.5m + L.T.Debt 11.4m))
RoIC = -7.23% (negative operating profit) (NOPAT -41.9m / Invested Capital 579.8m)
WACC = 15.54% (E(2.25b)/V(2.27b) * Re(15.59%) + D(13.4m)/V(2.27b) * Rd(9.57%) * (1-Tc(0.21)))
Discount Rate = 15.59% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 2.03%
[DCF] Terminal Value 44.35% ; FCFF base≈75.9m ; Y1≈49.8m ; Y5≈22.7m
[DCF] Fair Price = 8.83 (EV 202.5m - Net Debt -177.6m = Equity 380.1m / Shares 43.1m; r=15.54% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: -15.40 | EPS CAGR: -27.76% | SUE: 0.94 | # QB: 14
Revenue Correlation: 32.37 | Revenue CAGR: 2.99% | SUE: 0.47 | # QB: 0
EPS next Quarter (2026-04-30): EPS=0.10 | Chg7d=+0.037 | Chg30d=+0.037 | Revisions Net=+4 | Analysts=12
EPS current Year (2027-01-31): EPS=0.75 | Chg7d=+0.133 | Chg30d=+0.133 | Revisions Net=+7 | Growth EPS=+21.1% | Growth Revenue=+12.8%
EPS next Year (2028-01-31): EPS=1.09 | Chg7d=+0.225 | Chg30d=+0.225 | Revisions Net=+1 | Growth EPS=+44.6% | Growth Revenue=+13.7%
[Analyst] Revisions Ratio: +0.67 (5 Up / 1 Down within 30d for Next Quarter)